Allworth Financial’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.1K Hold
426
﹤0.01% 1990
2025
Q4
$80.6K Buy
426
+306
+255% +$56.6K ﹤0.01% 1883
2025
Q3
$19.9K Hold
120
﹤0.01% 2714
2025
Q2
$18.4K Hold
120
﹤0.01% 2570
2025
Q1
$18K Hold
120
﹤0.01% 2143
2024
Q4
$19.4K Hold
120
﹤0.01% 2128
2024
Q3
$21.3K Hold
120
﹤0.01% 1869
2024
Q2
$21.1K Hold
120
﹤0.01% 1845
2024
Q1
$20K Hold
120
﹤0.01% 1774
2023
Q4
$19.8K Hold
120
﹤0.01% 1657
2023
Q3
$18.7K Hold
120
﹤0.01% 1563
2023
Q2
$18.7K Hold
120
﹤0.01% 1584
2023
Q1
$19.5K Hold
120
﹤0.01% 1467
2022
Q4
$19.2K Hold
120
﹤0.01% 1382
2022
Q3
$17K Hold
120
﹤0.01% 1357
2022
Q2
$17K Sell
120
-1
-0.8% -$149 ﹤0.01% 1295
2022
Q1
$20K Sell
121
-32
-21% -$5.18K ﹤0.01% 1253
2021
Q4
$29K Buy
153
+1
+0.7% +$193 ﹤0.01% 983
2021
Q3
$31K Hold
152
﹤0.01% 904
2021
Q2
$31K Hold
152
﹤0.01% 734
2021
Q1
$27K Buy
152
+120
+375% +$21.7K ﹤0.01% 712
2020
Q4
$5K Buy
+32
New +$5.27K ﹤0.01% 973
2020
Q3
Sell
-32
Closed -$5K 1165
2020
Q2
$5K Buy
+32
New +$4.86K ﹤0.01% 852

Other funds holding BBH

Allworth Financial's BBH Position: Q1 2026 in Review

Allworth Financial held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 426 shares worth $80.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Allworth Financial first reported a position in BBH in Q2 2020 and has held it in 23 quarters since. The position peaked at $80.6K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Allworth Financial held 426 shares of VanEck Biotech ETF worth $80.1K as of Q1 2026.
  • Allworth Financial left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #1990 holding.
  • Allworth Financial first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 23 quarters since.
  • Allworth Financial's VanEck Biotech ETF position peaked at $80.6K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.